EGF816 Exerts Anticancer Effects in Non–Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor-Reference-Cited by-同舟云学术

EGF816 Exerts Anticancer Effects in Non–Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor

Published:2016-01-29 Issue:6 Volume:76 Page:1591-1602
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Jia Yong,Juarez Jose,Li Jie,Manuia Mari,Niederst Matthew J.,Tompkins Celin,Timple Noelito,Vaillancourt Mei-Ting,Pferdekamper AnneMarie Culazzo,Lockerman Elizabeth L.,Li Chun,Anderson Jennifer,Costa Carlotta,Liao Debbie,Murphy Eric,DiDonato Michael,Bursulaya Badry,Lelais Gerald,Barretina Jordi,McNeill Matthew,Epple Robert,Marsilje Thomas H.,Pathan Nuzhat,Engelman Jeffrey A.,Michellys Pierre-Yves,McNamara Peter,Harris Jennifer,Bender Steven,Kasibhatla Shailaja

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capmatinib plus nazartinib in patients with EGFR-mutated non–small cell lung cancer;European Journal of Cancer;2024-09

2. Current clinical practice and physicians’ insights on Chinese patients with advanced non-small cell lung cancer habouring epidermal growth factor receptor 20 insertion mutation;BMC Cancer;2024-08-23

3. Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2: Promising candidates for anticancer therapy;Journal of Molecular Structure;2024-08

4. Discovery of 1H-benzo[d]imidazole-(halogenated) Benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors;Pharmaceuticals;2024-06-26

5. Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer;Lung Cancer;2024-06